Friday, November 19th

MORNING

08.30-10.30

BIOMOLECULAR, GENETIC AND PATHOLOGIC FEATURES OF CARDIA CANCER
Paolo Dellabona, Sheila Krishnadath

08.30

The role of macrophages in solid tumors development
Michele De Palma

08.45

EGJ cancer: is there a molecular border?
Rupert Langer

09.00

Cardia cancer: is it still useful to maintain a separate classification between esophageal and gastric neoplasia?
Roberto Fiocca

09.15

Which is the clinical impact of CTC and circulating DNA in real clinical life? And tomorrow?
Nikolas Stoecklein

09.30

“The ecstasy and agony” of predictive biomarkers in current personalized medicine
Matteo Fassan

09.45

Optimization of molecular-guided therapies in metastatic EGJ cancer
Silvia Giordano

10.00

Why do I bust my balls every day on these issues? The perspective of a young oncological surgeon
Maria Bencivenga

11.00-13.00

ONCOLOGICAL FEATURES IN EGJ CANCER
Henk Hartgrink, Sheila Krishnadath

11.00

May radiomics play a role in diagnostic, staging and re-staging of cardia cancer?
Claudio Fiorino

11.15

Perioperative chemotherapy or chemoradiotherapy in junctional cancer
Stefano Cascinu

11.30

Is microsatellite instability a criterion of choice for perioperative chemotherapy?
Elizabeth Smyth

11.45

Immunotherapy of cardia cancer: which is the real clinical impact?
Markus Möhler

12.00

Adjuvant chemoterapy in the era of ct-DNA
Sara Lonardi

12.15

Molecular-based patient selection and treatment in cardia cancer
Sheila Krishnadath

12.30

Drop out of fragile patient during neoadjuvant treatment: what we should do?
Paolo Morgagni

12.45

Pushing the borders of stage IV: do target therapies and immunotherapy really change treatment strategies?
Jan Van Lanschot

13.00

Posters Round

13.30

Lunch

08.30-10.30

MINIMALLY INVASIVE SURGERY IN GASTRIC CANCER: CRITICAL QUESTIONS
Hans Meyer, Riccardo Rosati

08.30

Total gastrectomy: which reconstruction?
Domenico D’Ugo

08.45

Do results of RCT solve the problems in advanced gastric cancer?
Ines Gockel

09.00

Any news about MI after neoadjuvant chemotherapy?
Mark van Berge Henegouwen

09.15

Borman IV, cT4b, paraortic N+: are they borders for MIS?
Stefan Mönig

09.30

ICG: is it a technical, oncological enhancement or a business?
Han-Kwang Yang

09.45

ERAS and MI surgery: are they synonymous?
Shaun Preston

10.00

Real life in Western countries: is there a harmony between clinical studies and daily practice?
Paul Scheneider

11.00-13.00

ESOPHAGEAL EMERGENCIES
Michel Griffin, Tony Lerut

11.00

Do minimally invasive approaches have a role in the treatment of esophageal perforations?
Luigi Bonavina

11.15

Reconstruction techniques after esophageal caustic injuries: when and how?
Mircea Chirica

11.30

The Pittsburgh score: is it a valuable tool to predict outcome in esophageal perforation?
Magnus Nilsson

11.45

Esophageal stenting for refractory variceal bleeding
Lorella Fanti

12.00

The role of stents in first line treatment of esophageal perforations
Peter Siersema

12.15

Management of giant paraesophageal hernia in emergency
Mario Costantini

12.30

The use of flap reinforcement in esophageal perforation repair: is it worthwhile and when?
Paolo Parise

13.00

Posters Round

13.30

Lunch

08.45-13.00

Oral communications

08.30

08.45

09.00

09.15

09.30

09.45

10.00

11.00-13.00

11.00

11.15

11.30

11.45

12.00

12.15

12.30

12.45

13.00

13.30

CARDIA MEETING

AFTERNOON

14.30-16.30

SURGICAL AND ENDOSCOPIC TREATMENT OF EGJ CANCER
Jan Van Lanschot

14.30

Surgical approach to advanced Siewert 2 cancer: beyond the borders? The West side
Arnulf Hölscher

14.45

Surgical approach to advanced Siewert 2 cancer: beyond the borders? The East side
Takeshi Sano

15.00

Challenges in endoscopic treatment of cardia cancer: extension and depth
Roos Pouw

15.15

Lymphadenectomy in Siewert 2: does histology matter?
Philippe Nafteux

15.30

Esophago-gastro-anastomosi in MI Ivor: what is the best choice?
Theodore Liakakos

15.45

Positive proximal margin after esophageal resection of cardia cancer: causes and management
Bas Wijnnhoven

16.00

Quality of life after resection of the cardias: esophagectomy, total gastrectomy and partial resections
Andrew Davies

16.15

Factors that may improve the results of surgery for cancer of the cardia
John Reynolds

17.00-18.30

SURVEY PRESENTATION AND INTERSOCIETY MDTB ON CLINICAL CASES

17.00

Survey presentation
Simone Giacopuzzi

17.15

Case 1 | discussion MDTB
Moderator: Stefano Rausei

17.20

Pathologist
Mar Iglesias

17.25

Radiologist
Francesco De Cobelli

17.30

Oncologist
Elisabeth Smyth

17.35

Surgeon
Paulo Matos da Costa

17.40

Case 2 | discussion MDTB
Moderator: Stefano Rausei

17.45

Pathologist
Anna Tomezzoli

17.50

Radiologist
Maria Antonietta Mazzei

17.55

Oncologist
Sara Lonardi

18.00

Surgeon
Wojciech Polkowski

18.05

Toward harmonization
William Allum

18.30

ESDE General Assembly

14.30-16.30

GASTRIC CANCER | POORLY COHESIVE TUMOURS
Luca Saragoni, Michael Vieth

14.30

Epidemiology of PC gastric cancer: do we have reliable data?
Paulo Kassab

14.45

Harmonization of pathological classifications between the East and the West
Fátima Carneiro

15.00

Does morphology reflect molecular pathology in PC cancers?
Florence Renaud

15.15

Current practice of tailored surgery in PC gastric and EGJ tumors
Guillaume Piessen

15.30

Current practice of tailored oncological treatment in PC gastric and EGJ tumors
Ferdinando De Vita

15.45

Chemoresistance and potentially targetable molecular pathways in PC tumors
Davide Melisi

16.00

Tumor/stroma relationship in PC tumors
Heike Grabsch

16.15

Yes … but … now? A pocket guide for PC management
Giovanni de Manzoni

17.00-19.00

Oral communications

17.00

17.15

17.20

17.25

17.30

17.35

17.40

17.45

17.50

17.55

18.00

18.05

19.00

IGCA eu chapter General Assembly

14.30-16.30

Oral communications

14.30

14.45

15.00

15.15

15.30

15.45

16.00

16.15

17.00-18.30

UGIRA MEETING

17.00

17.15

17.20

17.25

17.30

17.35

17.40

17.45

17.50

17.55

18.00

18.05

18.30